References
Bakre MM, Sopory S, Visweswariah SS (2000). Expression and regulation of the cGMP-binding, cGMP-specific phosphodiesterase (PDE5) in human colonic epithelial cells: role in the induction of cellular refractoriness to the heat-stable enterotoxin peptide. J Cell Biochem 77 (1): 159-167.
Boden WE, Padala SK, Cabral KP, Buschmann IR, Sidhu MS (2015). Role of short-acting nitroglycerin in the management of ischemic heart disease.Drug Des Devel Ther 9: 4793-4805.
Browning DD (2019). The enduring promise of phosphodiesterase 5 inhibitors for colon cancer prevention. Translational gastroenterology and hepatology 4: 83.
Chamorro-Jorganes A, Grande MT, Herranz B, Jerkic M, Griera M, Gonzalez-Nuñez M, et al. (2010). Targeted genomic disruption of h-ras induces hypotension through a NO-cGMP-PKG pathway-dependent mechanism. Hypertension 56 (3): 484-489.
Chang WL, Masih S, Thadi A, Patwa V, Joshi A, Cooper HS, et al.(2017). Plecanatide-mediated activation of guanylate cyclase-C suppresses inflammation-induced colorectal carcinogenesis in Apc+/Min-FCCC mice. World J Gastrointest Pharmacol Ther8 (1): 47-59.
Cohen JL, Nees SN, Valencia GA, Rosenzweig EB, Krishnan US (2019). Sildenafil Use in Children with Pulmonary Hypertension. J Pediatr205: 29-34 e21.
Drüeke TB, Devuyst O (2019). Blood pressure measurement in mice: tail-cuff or telemetry? Kidney Int 96 (1): 36.
Dunn PJ (2005). Synthesis of Commercial Phosphodiesterase (V) Inhibitors. Org. Process Res. Dev. 9 (1): 9.
Forte LR, Jr. (2004). Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics. Pharmacol Ther104 (2): 137-162.
Golde WT, Gollobin P, Rodriguez LL (2005). A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab Anim (NY) 34 (9): 39-43.
Gupta M, Kovar A, Meibohm B (2005). The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction. J Clin Pharmacol 45 (9): 987-1003.
Hatzimouratidis K (2014). A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction. Therapeutic Advances in Urology6 (4): 135-147.
Hong JH, Kwon YS, Kim IY (2017). Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors. Expert Opin Drug Metab Toxicol 13 (2): 183-192.
Hou Y, Wren A, Mylarapu N, Browning K, Islam BN, Wang R, et al.(2022). Inhibition of Colon Cancer Cell Growth by Phosphodiesterase Inhibitors Is Independent of cGMP Signaling. J Pharmacol Exp Ther381 (1): 42-53.
Huang W, Sundquist J, Sundquist K, Ji J (2019). Use of Phosphodiesterase 5 Inhibitors Is Associated With Lower Risk of Colorectal Cancer in Men With Benign Colorectal Neoplasms. Gastroenterology157 (3): 672-681 e674.
Islam BN, Browning DD (2018). Phosphodiesterase-5 inhibitors for colon cancer chemoprevention. Aging (Albany NY)10 (9): 2216-2217.
Islam BN, Sharman SK, Hou Y, Bridges AE, Singh N, Kim S, et al.(2017). Sildenafil Suppresses Inflammation-Driven Colorectal Cancer in Mice. Cancer Prev Res (Phila) 10 (7): 377-388.
Islam BN, Sharman SK, Hou Y, Wang R, Ashby J, Li H, et al.(2022). Type-2 cGMP-dependent protein kinase suppresses proliferation and carcinogenesis in the colon epithelium. Carcinogenesis .
Kim DK, Lee JY, Lee N, Ryu DH, Kim JS, Lee S, et al. (2001a). Synthesis and phosphodiesterase inhibitory activity of new sildenafil analogues containing a carboxylic acid group in the 5’-sulfonamide moiety of a phenyl ring. Bioorg Med Chem 9 (11):3013-3021.
Kim DK, Lee N, Lee JY, Ryu DH, Kim JS, Lee SH, et al. (2001b). Synthesis and phosphodiesterase 5 inhibitory activity of novel phenyl ring modified sildenafil analogues. Bioorg Med Chem9 (6): 1609-1616.
Kim DK, Ryu DH, Lee N, Lee JY, Kim JS, Lee S, et al. (2001c). Synthesis and phosphodiesterase 5 inhibitory activity of new 5-phenyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one derivatives containing an N-acylamido group phenyl ring. Bioorg Med Chem9 (7): 1895-1899.
Kim J, Ji H, Kim SJ, Lee HW, Lee SS, Kim DS, et al. (2003). Simultaneous determination of sildenafil and its active metabolite UK-103,320 in human plasma using liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 32 (2):317-322.
Lee DL, Leite R, Fleming C, Pollock JS, Webb RC, Brands MW (2004). Hypertensive response to acute stress is attenuated in interleukin-6 knockout mice. Hypertension 44 (3): 259-263.
Li P, Schulz S, Bombonati A, Palazzo JP, Hyslop TM, Xu Y, et al.(2007). Guanylyl Cyclase C Suppresses Intestinal Tumorigenesis by Restricting Proliferation and Maintaining Genomic Integrity.Gastroenterology 133 (2): 599-607.
Lilley E, Stanford SC, Kendall DE, Alexander SPH, Cirino G, Docherty JR, et al. (2020). ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020. Br J Pharmacol177 (16): 3611-3616.
Lin JE, Li P, Snook AE, Schulz S, Dasgupta A, Hyslop TM, et al.(2010). The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling. Gastroenterology138 (1): 241-254.
Lipinski CA (2004). Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1 (4):337-341.
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev46 (1-3): 3-26.
Nichols DJ, Muirhead GJ, Harness JA (2002). Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality. Br J Clin Pharmacol 53 Suppl 1: 5S-12S.
Oruc Z, Kaplan MA (2019). Effect of exercise on colorectal cancer prevention and treatment. World J Gastrointest Oncol11 (5): 348-366.
Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, et al. (2020). Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol18 (7): e3000411.
Roos VH, Mangas-Sanjuan C, Rodriguez-Girondo M, Prado LM, Steyerberg EW, Bossuyt PMM, et al. (2019). Effects of Family History on Relative and Absolute Risks for Colorectal Cancer: a Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol .
Sachdev R, Sao R, Birk JW, Anderson JC, Levine J (2019). Update in Surveillance Recommendations in Individuals With Conventional Adenomas.Curr Treat Options Gastroenterol 17 (2):303-312.
Shailubhai K, Yu HH, Karunanandaa K, Wang JY, Eber SL, Wang Y, et al. (2000). Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP. Cancer Res 60 (18):5151-5157.
Sharman SK, Islam BN, Hou Y, Singh N, Berger FG, Sridhar S, et al. (2018). Cyclic-GMP-Elevating Agents Suppress Polyposis in Apc(Min) mice by Targeting the Preneoplastic Epithelium. Cancer Prev Res (Phila) 11 (2): 81-92.
Sharman SK, Islam BN, Hou Y, Usry M, Bridges A, Singh N, et al.(2017). Sildenafil normalizes bowel transit in preclinical models of constipation. PLoS One 12 (4): e0176673.
Steinbrecher KA, Wowk SA, Rudolph JA, Witte DP, Cohen MB (2002). Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation. Am J Pathol161 (6): 2169-2178.
Tomasetti C, Li L, Vogelstein B (2017). Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science355 (6331): 1330-1334.
Veettil SK, Teerawattanapong N, Ching SM, Lim KG, Saokaew S, Phisalprapa P, et al. (2017). Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials. Onco Targets Ther 10: 2689-2700.
Wagner MS, Burgess J, Britt RC (2019). Barriers to Colonoscopy in an Uninsured Patient Population-A Quality Improvement Project. Am Surg 85 (1): 111-114.
Walker DK, Ackland MJ, James GC, Muirhead GJ, Rance DJ, Wastall P, et al. (1999). Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Xenobiotica 29 (3):297-310.
Wang R, Kwon IK, Singh N, Islam B, Liu K, Sridhar S, et al.(2014). Type 2 cGMP-dependent protein kinase regulates homeostasis by blocking c-Jun N-terminal kinase in the colon epithelium. Cell Death Differ 21 (3): 427-437.
Wang R, Kwon IK, Thangaraju M, Singh N, Liu K, Jay P, et al.(2012). Type 2 cGMP-Dependent Protein Kinase Regulates Proliferation and Differentiation in the Colonic Mucosa. Am J Physiol Gastrointest Liver Physiol 303 (2): G209-219.
Yao Y, Suo T, Andersson R, Cao Y, Wang C, Lu J, et al. (2017). Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas. Cochrane Database Syst Rev 1: CD003430.
Yoo J, Thai K-M, Kim D-K, Lee JY, Park H-J (2007). 3D-QSAR studies on sildenafil analogues, selective phosphodiesterase 5 inhibitors.Bioorganic & Medicinal Chemistry Letters17 (15): 4271-4274.
Zhao S, Wang S, Pan P, Xia T, Chang X, Yang X, et al. (2019). Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis.Gastroenterology 156 (6): 1661-1674 e1611.